{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-159289","form_type":"8-K","ticker":"RVMD","cik":"0001628171","company_name":"Revolution Medicines, Inc.","filed_at":"2026-04-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.614748+00:00","generated_at":"2026-05-15T05:47:11.160823+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Revolution Medicines raises ~$2.15B via equity and convertible note offerings","bullets":["Equity offering: 10,563,381 shares at $142/sh + full over-allotment of 1,584,506 shares; net proceeds ~$1.65B.","Convertible note offering: $500M aggregate principal of 0.50% Convertible Senior Notes due 2033.","Equity closed April 16; note offering expected to close April 17; underwriters J.P. Morgan, TD Securities, Guggenheim."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-159289","json":"https://secwatch.observer/filing/0001193125-26-159289.json","markdown":"https://secwatch.observer/filing/0001193125-26-159289.md","text":"https://secwatch.observer/filing/0001193125-26-159289.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628171/000119312526159289/0001193125-26-159289-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628171/000119312526159289/d95226d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T05:47:11.160823+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}